Fischer Medical Ventures Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	12.08	18.38	-0.37	-2.33	1.41	Upgrade
Depreciation & Amortization	8.05	1.82	-	-	-	Upgrade
Provision & Write-off of Bad Debts	1.85	-	-	-	-	Upgrade
Other Operating Activities	12.05	2.92	0.52	0.44	-1.58	Upgrade
Change in Accounts Receivable	-533.82	-347.09	-1.71	-	-	Upgrade
Change in Inventory	-34.07	175.21	-	-	-	Upgrade
Change in Accounts Payable	141.81	99.39	0.07	0.03	-0.25	Upgrade
Change in Other Net Operating Assets	-475.33	-24.15	0.02	0.09	-0.15	Upgrade
Operating Cash Flow	-867.38	-73.52	-1.46	-1.77	-0.57	Upgrade
Capital Expenditures	-59.87	-4.85	-	-	-	Upgrade
Investment in Securities	-1,197	-309	-	-	-	Upgrade
Other Investing Activities	7.72	-0.01	-	-	-	Upgrade
Investing Cash Flow	-1,249	-313.86	-	-	-	Upgrade
Long-Term Debt Issued	598.79	-	1.68	1.49	-	Upgrade
Long-Term Debt Repaid	-	-5.72	-	-	-	Upgrade
Net Debt Issued (Repaid)	598.79	-5.72	1.68	1.49	-	Upgrade
Issuance of Common Stock	2,553	382.6	-	-	-	Upgrade
Other Financing Activities	-2.97	-6.31	-0.02	-0.01	-0.01	Upgrade
Financing Cash Flow	3,149	370.57	1.66	1.48	-0.01	Upgrade
Miscellaneous Cash Flow Adjustments	0.05	25.93	0	-	-	Upgrade
Net Cash Flow	1,033	9.13	0.2	-0.29	-0.59	Upgrade
Free Cash Flow	-927.26	-78.37	-1.46	-1.77	-0.57	Upgrade
Free Cash Flow Margin	-83.76%	-37.35%	-81.28%	-	-34.73%	Upgrade
Free Cash Flow Per Share	-0.60	-0.46	-0.85	-1.03	-0.33	Upgrade
Cash Income Tax Paid	9.23	0.49	0.02	0.01	0.01	Upgrade
Levered Free Cash Flow	-555.86	-281.86	-1.62	-1.12	-0.62	Upgrade
Unlevered Free Cash Flow	-553.35	-281.44	-1.52	-1.06	-0.51	Upgrade
Change in Working Capital	-901.41	-96.64	-1.61	0.12	-0.4	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.